Will PepVise recommend a peptide vendor?

No. Ever. This is the hardest editorial line at PepVise and it is not a commercial choice, it is what lets the site be trusted on everything else. We do not recommend research-chemical vendors, compounding pharmacies, or telehealth peptide clinics. We describe the taxonomy, the regulatory framework, and the red flags. The specific decision of where to obtain a compound is between a reader and their licensed physician, operating within the compliance framework their situation demands.

Is there really a difference between a '503A pharmacy' and a 'research-chemical supplier'?

Yes, a substantial one. A 503A pharmacy holds state board of pharmacy licensure, dispenses against valid patient-specific prescriptions, uses permitted bulk drug substances, and is subject to FDA inspection. A research-chemical supplier holds none of those things. Verifying a claimed 503A pharmacy is a thirty-second check on the state board's license lookup. Verifying a research-chemical vendor's claims is substantially harder because there is rarely an analogous registry.

What is the single most informative red flag?

Vendors who market RUO-labeled material with explicit references to human dosing, injection protocols, or cycling schedules. That pattern is the exact conduct FDA enforcement has targeted in 2023-2024 warning letters, and it correlates with weaker practice on purity, identity, and shipping. If a vendor's marketing describes how to use the product in humans, the RUO label is performative and the compliance posture is weak.

How does someone verify a Certificate of Analysis?

Ideally: by requesting the independent third-party assay report (HPLC purity, mass spectrometry identity), identifying the accredited laboratory that performed it, and verifying the lab's credentials. Vendor-generated COAs without independent lab identification are weak evidence. Some independent assay services will run a sample for a fee; this is expensive but is the actual verification step, rather than a visual check on a PDF.

What about compounded peptides from a telehealth clinic?

Telehealth peptide prescribing spans a real range of rigor. The questions to ask are specific: is the prescribing physician licensed in the patient's state, is the dispensing pharmacy a properly licensed 503A entity, is there actual patient-specific evaluation (not a checkbox form), is there informed consent, and is there follow-up. A clinic that can answer those questions substantively is operating inside the framework. A clinic that cannot is closer to Category D with a medical-costume on.

Why not just publish which vendors are good?

Because we have no independent assay operation, no ongoing audit of any vendor, and no way to verify purity at any given shipment. A 'best vendor' recommendation from PepVise would be exactly the kind of content the site was founded to replace, the vendor-owned 'educational' post dressed as editorial. The taxonomy, the red flags, and the regulatory framework are what we can speak to with integrity. The specific purchase decision is not.

Explainer· Regulation

Where to buy peptides, the taxonomy

By The PepVise Editorial Team · Reviewed April 21, 2026 · 14 min read

Research-chemical suppliers versus compounding pharmacies versus underground sellers, the legal framework and red flags. No vendor directory.

Mechanism explainers on PepVise aim for textbook-level clarity without the textbook's refusal to commit to a reading.

Frequently asked

What readers ask us next.

Will PepVise recommend a peptide vendor?: No. Ever. This is the hardest editorial line at PepVise and it is not a commercial choice, it is what lets the site be trusted on everything else. We do not recommend research-chemical vendors, compounding pharmacies, or telehealth peptide clinics. We describe the taxonomy, the regulatory framework, and the red flags. The specific decision of where to obtain a compound is between a reader and their licensed physician, operating within the compliance framework their situation demands.
Is there really a difference between a '503A pharmacy' and a 'research-chemical supplier'?: Yes, a substantial one. A 503A pharmacy holds state board of pharmacy licensure, dispenses against valid patient-specific prescriptions, uses permitted bulk drug substances, and is subject to FDA inspection. A research-chemical supplier holds none of those things. Verifying a claimed 503A pharmacy is a thirty-second check on the state board's license lookup. Verifying a research-chemical vendor's claims is substantially harder because there is rarely an analogous registry.
What is the single most informative red flag?: Vendors who market RUO-labeled material with explicit references to human dosing, injection protocols, or cycling schedules. That pattern is the exact conduct FDA enforcement has targeted in 2023-2024 warning letters, and it correlates with weaker practice on purity, identity, and shipping. If a vendor's marketing describes how to use the product in humans, the RUO label is performative and the compliance posture is weak.
How does someone verify a Certificate of Analysis?: Ideally: by requesting the independent third-party assay report (HPLC purity, mass spectrometry identity), identifying the accredited laboratory that performed it, and verifying the lab's credentials. Vendor-generated COAs without independent lab identification are weak evidence. Some independent assay services will run a sample for a fee; this is expensive but is the actual verification step, rather than a visual check on a PDF.
What about compounded peptides from a telehealth clinic?: Telehealth peptide prescribing spans a real range of rigor. The questions to ask are specific: is the prescribing physician licensed in the patient's state, is the dispensing pharmacy a properly licensed 503A entity, is there actual patient-specific evaluation (not a checkbox form), is there informed consent, and is there follow-up. A clinic that can answer those questions substantively is operating inside the framework. A clinic that cannot is closer to Category D with a medical-costume on.
Why not just publish which vendors are good?: Because we have no independent assay operation, no ongoing audit of any vendor, and no way to verify purity at any given shipment. A 'best vendor' recommendation from PepVise would be exactly the kind of content the site was founded to replace, the vendor-owned 'educational' post dressed as editorial. The taxonomy, the red flags, and the regulatory framework are what we can speak to with integrity. The specific purchase decision is not.

The sources

References cited on this page.

PubMed, ClinicalTrials.gov, and FDA documents only. Secondary sources appear when needed to characterize public discourse, never as a source for a clinical claim.

The masthead

About The Pepvise Editorial Team

The Pepvise Editorial Team is a small group of researchers and science writers reading the peer-reviewed peptide literature and translating it into calm, cited analysis. We do not sell peptides, recommend peptides, or tell readers what to administer. We describe what has been measured, by whom, at what scale, with what effect size.

Compound reviews are signed off by Dr. Priya Narang, MD, MPH (endocrinologist) and Dr. Marcus Haley, PharmD, BCPS (board-certified clinical pharmacist). Both hold verifiable state-board licenses and have signed editorial-independence letters with us. See the full editorial board →

Adjacent in the literature.

Regulation · Compound profile

"Research Use Only", What It Actually Means

FDA's position on research-use-only labeling, the 503A/503B distinction, the 2023 enforcement actions, and what this framing means for buyers.

12 min read

Regulation · Compound profile

Peptide Therapy: What Clinics Sell vs What Is Proven

Wellness clinics offer peptide therapy for recovery, anti-aging and fat loss. What the term actually covers, which peptides are FDA-approved for what, and the regulatory grey zone most of it lives in.

11 min read

Get the 2026 Peptide Evidence Ledger.

A 12-page PDF summary of where 10 major compounds sit, Preclinical / Human pilot / Phase trial / FDA status. Updated quarterly. Free.

By subscribing, you agree to our Privacy Policy. One calm, cited email a week. Unsubscribe anytime.